Researchers have shown that TAK‐242 selectively binds to TLR4, disrupts the interaction between LPS and TLR4, and inhibits downstream signaling pathways, which is effective in treating H. pylori‐associated gastric cancer.247. Here, TLR4 is linked to gastric cancer.